Malaria Clinical Trial
— REPELMALARIAOfficial title:
Evaluation of IR3535 as a Spatial Repellent for Malaria Control. (Avaliação da eficácia do Repelente Ambiental 3-(N-acetyl-n-butyl) Aminopropionic Acid Ethyl Ester (IR3535) Como Ferramenta Para o Controlo da malária).
Verified date | December 2023 |
Source | Universidade Nova de Lisboa |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Mozambique contributes with 5% of global malaria cases, and despite control efforts the Sofala province continues to experience a high burden of malaria. The resistance to insecticides and changes in vector habits can compromise the use of common vector control tools. The use of spatial repellents is thus an interesting alternative, as it does not exert selective pressure on resistance genes or eliminate other insects with impact on biodiversity. IR3535 is a non-toxic repellent and if used at community level can extend protection to outdoor biting. Hypothesis: Using the IR3535 repellent for indoor and outdoor spraying will reduce the prevalence of malaria and reduce vector density and infection. An experimental Before-After-Control-Intervention will be carried out with two groups: a) Intervention (Tambai Q2 and Q6): with intra and extra-household spraying with IR3535 and b) Control (Tambai Q3 and Q4): without spraying. Tambai is acommunity of Bebedo, Nhamatanda, Sofala, Mozambique. The mosquito distribution, diversity, density and sporozoite rate will be monitored indoors and outdoors in both communities for 2 years. The prevalence of malaria will be determined in under five years old children at the beginning, the end of the 1st year and at the end of the study. Additionally, cross-sectional studies with a mixed approach assessing the community knowledge, attitudes and practices (KAP) will be carried out to detect gaps that persist at the community level. Heads of households and health professionals will be interviewed at the beginning of the study, the end of 1st year and at the end of the study. The data will be analyzed using SPSS and R software packages. For matching situations (before and after), the McNemar test will be used to ascertain statistical significance. Generalized Linear Models (GLM) will be used to jointly analyze several explanatory variables. Linear Mixed Models (LMM) and Generalized Estimation Equation (GEE) models will be used to compare longitudinal data. The prevalence of malaria and entomological indices relevant for transmission are expected to decrease with the intervention while community knowledge on malaria and its control are expected to increase.
Status | Active, not recruiting |
Enrollment | 166 |
Est. completion date | December 30, 2024 |
Est. primary completion date | June 30, 2024 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 6 Months and older |
Eligibility | Inclusion Criteria for children: - aged 6 to 59 months - resident in the communities under study - to give informed consent for participation by parents or legal representatives - availability on the day of the study. Exclusion Criteria for children: - aged below 6 months and older than 59 months - being infected with or having undergone malaria treatment for up to one month - lack of consent from parents or legal representatives. Inclusion Criteria for heads of household and health professionals: - Be the head of household or someone appointed by her/him and a resident at the place of study - Be a health professional in the area of Vinho health center - Be available on the day of the interview - Have consented to participate in the study Exclusion Criteria for heads of household and health professionals: • Having a mental illness or having a change in behavior |
Country | Name | City | State |
---|---|---|---|
Mozambique | Centro de Investigação Operacional da Beira, Instituto Nacional de Saúde, Ministério de Saúde, Mozambique | Beira | Sofala |
Lead Sponsor | Collaborator |
---|---|
Universidade Nova de Lisboa | Centro de Investigação Operacional da Beira, Mozambique, Fundação Belmiro de Azevedo, Portugal |
Mozambique,
Abilio AP, Kleinschmidt I, Rehman AM, Cuamba N, Ramdeen V, Mthembu DS, Coetzer S, Maharaj R, Wilding CS, Steven A, Coleman M, Hemingway J, Coleman M. The emergence of insecticide resistance in central Mozambique and potential threat to the successful indoor residual spraying malaria control programme. Malar J. 2011 May 2;10:110. doi: 10.1186/1475-2875-10-110. — View Citation
Abilio AP, Marrune P, de Deus N, Mbofana F, Muianga P, Kampango A. Bio-efficacy of new long-lasting insecticide-treated bed nets against Anopheles funestus and Anopheles gambiae from central and northern Mozambique. Malar J. 2015 Sep 17;14:352. doi: 10.1186/s12936-015-0885-y. — View Citation
DETINOVA TS. Age-grouping methods in Diptera of medical importance with special reference to some vectors of malaria. Monogr Ser World Health Organ. 1962;47:13-191. No abstract available. — View Citation
Dickin SK, Schuster-Wallaceab CJ, Elliottc SJ. Mosquitoes & vulnerable spaces: Mapping local knowledge of sites for dengue control in Seremban and Putrajaya Malaysia. Applied Geography. 2014. 46: 71-79. DOI: 10.1016/j.apgeog.2013.11.003
Escamilla V, Emch M, Dandalo L, Miller WC, Martinson F, Hoffman I. Sampling at community level by using satellite imagery and geographical analysis. Bull World Health Organ. 2014 Sep 1;92(9):690-4. doi: 10.2471/BLT.14.140756. Epub 2014 Jun 17. — View Citation
Faul F, Erdfelder E, Buchner A, Lang AG. Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses. Behav Res Methods. 2009 Nov;41(4):1149-60. doi: 10.3758/BRM.41.4.1149. — View Citation
Faul F, Erdfelder E, Lang AG, Buchner A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 2007 May;39(2):175-91. doi: 10.3758/bf03193146. — View Citation
Marie A, Boissiere A, Tsapi MT, Poinsignon A, Awono-Ambene PH, Morlais I, Remoue F, Cornelie S. Evaluation of a real-time quantitative PCR to measure the wild Plasmodium falciparum infectivity rate in salivary glands of Anopheles gambiae. Malar J. 2013 Jul 2;12:224. doi: 10.1186/1475-2875-12-224. — View Citation
Morrison AC, Astete H, Chapilliquen F, Ramirez-Prada C, Diaz G, Getis A, Gray K, Scott TW. Evaluation of a sampling methodology for rapid assessment of Aedes aegypti infestation levels in Iquitos, Peru. J Med Entomol. 2004 May;41(3):502-10. doi: 10.1603/0022-2585-41.3.502. — View Citation
Ocholla H, Preston MD, Mipando M, Jensen AT, Campino S, MacInnis B, Alcock D, Terlouw A, Zongo I, Oudraogo JB, Djimde AA, Assefa S, Doumbo OK, Borrmann S, Nzila A, Marsh K, Fairhurst RM, Nosten F, Anderson TJ, Kwiatkowski DP, Craig A, Clark TG, Montgomery J. Whole-genome scans provide evidence of adaptive evolution in Malawian Plasmodium falciparum isolates. J Infect Dis. 2014 Dec 15;210(12):1991-2000. doi: 10.1093/infdis/jiu349. Epub 2014 Jun 19. — View Citation
Wampler PJ, Rediske RR, Molla AR. Using ArcMap, Google Earth, and Global Positioning Systems to select and locate random households in rural Haiti. Int J Health Geogr. 2013 Jan 18;12:3. doi: 10.1186/1476-072X-12-3. — View Citation
* Note: There are 11 references in all — Click here to view all references
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Changes from baseline in malaria prevalence in children under 5 years at 1st year | Malaria cases in children aged 6 to 59 months | Month 1, Month 12 | |
Primary | Changes from baseline in malaria prevalence in children under 5 years at 2nd year | Malaria cases in children aged 6 to 59 months | Month 1, Month 24 | |
Primary | Monthly changes of indoor Anopheles mosquito density from baseline to month 24 | Mosquitoes resting inside the houses will be collected by aspiration | 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18 19, 20, 21, 22, 23, 24 Months | |
Primary | Monthly changes of outdoor Anopheles mosquito density from baseline to month 24 | Outside mosquitoes collected overnight using CDC-light traps | 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18 19, 20, 21, 22, 23, 24 Months | |
Primary | Monthly changes of Anopheles mosquito sporozoite rate | Number of infected mosquitoes determined by PCR | 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18 19, 20, 21, 22, 23, 24 Months | |
Primary | Change from Baseline in Knowledge, attitudes and practices - KAP score at 1st year | An evaluation scale will be defined with the attribution of points for correct answers, and whoever has <50% will be considered a participant with a bad level of knowledge, attitudes and practices and whoever has 50% -74% and =75% will be considered medium and high level of knowledge, attitudes or practices respectively | Month 1, Month 12 | |
Primary | Change from Baseline in Knowledge, attitudes and practices - KAP score at 2nd | An evaluation scale will be defined with the attribution of points for correct answers, and whoever has <50% will be considered a participant with a bad level of knowledge, attitudes and practices and whoever has 50% -74% and =75% will be considered medium and high level of knowledge, attitudes or practices respectively | Month 1, Month 24 | |
Secondary | Mosquito breeding sites mapping | The mosquito breeding sites will be mapped using the "participatory mapping" approach (Dickin et al. 2014). Community generated maps will be digitized on a GIS to create a georeferenced map of community knowledge. | continuous for the 2 years | |
Secondary | Prevalence of symptomatic malaria cases in the area covered by the Vinho health center | Malaria cases in the locality of Bebedo will be monitored through patients of all ages with suspected malaria, attending the Vinho Health Center. Blood will be collected, for blood-smears and PCR. | continuous for the 2 years |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04601714 -
Baseline Cohort Malaria Morbidity Study
|
||
Withdrawn |
NCT04020653 -
A Study to Assess the Safety and Efficacy of 5-aminolevulinic Acid Hydrochloride (5-ALA HCl) and Sodium Ferrous Citrate (SFC) Added on Artemisinin-based Combination Therapy (ACT) in Adult Patients With Uncomplicated Malaria
|
Phase 2 | |
Terminated |
NCT04368910 -
Safety and Efficacy of Pyronaridine Artesunate Vs Chloroquine in Children and Adult Patients With Acute Vivax Malaria
|
Phase 3 | |
Completed |
NCT03641339 -
Defining Skin Immunity of a Bite of Key Insect Vectors in Humans
|
N/A | |
Completed |
NCT02544048 -
Markers of T Cell Suppression: Antimalarial Treatment and Vaccine Responses in Healthy Malian Adults
|
||
Completed |
NCT00527163 -
Role of Nitric Oxide in Malaria
|
||
Not yet recruiting |
NCT05934318 -
L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE)
|
N/A | |
Active, not recruiting |
NCT04704674 -
Community Dynamics of Malaria Transmission in Humans and Mosquitoes in Fleh-la and Marshansue, Salala District, Bong County, Liberia
|
||
Completed |
NCT03276962 -
Efficacy, Safety and Immunogenicity Study of GSK Biologicals' Candidate Malaria Vaccine (SB257049) Evaluating Schedules With or Without Fractional Doses, Early Dose 4 and Yearly Doses, in Children 5-17 Months of Age
|
Phase 2 | |
Completed |
NCT04966871 -
Safety, Tolerability and Efficacy of PfSPZ Vaccine Against Heterologous CHMI in US Malaria naïve Adults
|
Phase 1 | |
Completed |
NCT00289185 -
Study of Safety, Immunogenicity and Efficacy of a Candidate Malaria Vaccine in Tanzanian Infants
|
Phase 2 | |
Recruiting |
NCT03937817 -
Collection of Human Biospecimens for Basic and Clinical Research Into Globin Variants
|
||
Active, not recruiting |
NCT06153862 -
Africa Ready Malaria Screening
|
N/A | |
Completed |
NCT04545905 -
Antenatal Care as a Platform for Malaria Surveillance: Utilizing Community Prevalence Measures From the New Nets Project to Validate ANC Surveillance of Malaria in Burkina Faso
|
||
Recruiting |
NCT06278181 -
Diabetes, Metabolic Syndrome and Risk of Malaria in Cameroon
|
||
Withdrawn |
NCT02793388 -
A Trial on Supervised Primaquine Use in Ethiopia
|
Phase 4 | |
Completed |
NCT02909712 -
Cardiac Safety of Dihydroartemisinin-Piperaquine Amongst Pregnant Women in Tanzania
|
Phase 2 | |
Withdrawn |
NCT02793414 -
Diagnostic Utility of Volatile Organic Compounds in Human Breath for Acute Clinical Malaria in Ethiopia
|
||
Completed |
NCT02793622 -
Prevention of Malaria in HIV-uninfected Pregnant Women and Infants
|
Phase 3 | |
Completed |
NCT02527005 -
A Comparative Study of Azithromycin and S-P as Prophylaxis in Pregnant HIV+ Patients
|
Phase 1 |